Biomarkers in metabolic syndrome
- 문서 유형
- 연구출판물 · 저서
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- ADVANCES IN CLINICAL CHEMISTRY111 · pp.101 · 2022
- 피인용
- Scopus 25
- FWCI (Scopus)
- 5.9
- JCR IF
- JCR 2021 6.303
- ISSN
- 0065-2423
저자
- 조영혜제1저자Department of Family Medicine and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South Korea
- 이영인Department of Family Medicine and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South Korea
- 최정인Department of Family Medicine and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South Korea
- 이새롬Department of Family Medicine and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan, South Korea
- 이상엽교신저자Department of Medical Education, Pusan National University School of Medicine, Yangsan, South Korea
초록
© 2022 Elsevier Inc.Metabolic syndrome (MetS) is a global health challenge characterized as a group of risk factors for developing atherosclerotic cardiovascular disease. Although visceral adipose tissue, adipocyte dysfunction, chronic low-grade inflammation, and insulin resistance are fundamental to MetS, the exact biochemical mechanisms underlying this disease state remain unclear. Numerous biomarkers, however, have been proposed to improve our understanding of its complex pathophysiology and facilitate diagnosis. This review examines these biomarkers and clarifies their potential roles in the pathogenesis, diagnosis, prediction, progression, and severity of MetS and MetS-related disorders.
키워드
AdipocytokineBiomarkersInflammationInsulin resistanceLipoproteinMetabolic syndromeOxidative stressVisceral adipose tissue
식별자
- Scopus EID
- 2-s2.0-85137722285



로그인
연구물 목록으로